Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

29

Revenue 2017

Soliris

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Soliris was produced by Alexion.

Top biotech firms saw sales jump in 2014

Top biotech firms saw sales jump in 2014 Alexion saw sales from its orphan drug Soliris (eculizumab) increase from $1.6bn in 2013 to $2.2bn in 2014. ... Alexion reported a higher volume of unit shipments and better-than-expected demand for Soliris across all geographic regions, especially in

New cancer meds and drug extensions top CHMP recommendations

New cancer meds and drug extensions top CHMP recommendations This includes Adenuric, blockbuster oncology treatment Avastin (bevacizumab) from Roche; AbbVie's auto-inflammatory drug Humira (adalimumab), Menarini's gout drug Adenuric, (febuxostat), the rare disease drug for kidney disease Soliris

NICE backs first ‘ultra-orphan’ drug Soliris

NICE backs first ‘ultra-orphan’ drug Soliris Alexion's Soliris has become the first drug to pass through a new UK assessment to determine the cost-effectiveness of medicines for very rare conditions. ... These concerns have now been somewhat overcome, although cost still remains an issue and NICE

Assessing drugs for ultra-rare conditions in the UK

Assessing drugs for ultra-rare conditions in the UK Along the way Soliris underwent review by the now-defunct Advisory Group for National Specialised Services (AGNSS). ... Nevertheless, if it needed convincing about Soliris' cost, NICE was impressed with the drug's benefits.

NICE set to back Alexion's costly 'ultra-orphan' drug

NICE set to back Alexion's costly 'ultra-orphan' drug on high cost drugs - and Soliris' price has previously been a problem for NICE. ... Alexion estimated Soliris produced 25.22 additional QALYs per patient compared with standard care.

[ Previous 5 results ] 3 4 5 6 7 8 9 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...
OPEN Health use PR to support clinical trial recruitment
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...

Infographics